Gene Therapy

As per available reports about 100 journals, 162 Conferences, 30 workshops are presently dedicated exclusively to Gene Therapy and about 366282 articles are being published on the current Research and trends on Gene Therapy. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Gene Therapy are being carried out. Gene therapy is the use of DNA as a drug to treat disease by delivering therapeutic DNA into a patient's cells. The most common form of gene therapy involves using DNA that encodes a functional, therapeutic gene to replace a mutated gene. Other forms involve directly correcting a mutation, or using DNA that encodes a therapeutic protein drug (rather than a natural human gene) to provide treatment. In gene therapy, DNA that encodes a therapeutic protein is packaged within a "vector", which is used to get the DNA inside cells within the body. Once inside, the DNA becomes expressed by the cell machinery, resulting in the production of therapeutic protein, which in turn treats the patient's disease.Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery.

The Journal of Genetic Syndromes & Gene Therapy is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals on Fungus. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Genetic Syndromes & Gene Therapy a unique platform to researchers and scientist to explore the advanced and latest research developments in the area of Gene Therapy, thus bridging the gap between researchers and young scientists. OMICS International hosts over 400 leading-edge peer reviewed Open Access Journals and organize over 300 International Conferences annually all over the world. OMICS International journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities that ensure a rapid, quality and quick review process. OMICS International signed an agreement with more than 500 International Societies to make healthcare information Open Access.

OMICS International Conference Series would like to welcome all the Directors, Heads, Deans, Professors, Scientists, Researchers, Doctors and students of neurology department for “International conference on parkinson's disease and movement disorder”on August 11-13, 2015 at Frankfurt, Germany, The theme of Parkinson conference is based on “Leading innovation and remedial insight of parkinsons disease”. OMICS International Organises 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.